Abstract PS4-07-06: Independent validation of TNBCDX, a 15-gene genomic risk stratification tool for early-stage triple-negative breast cancerF. Brasó-Maristany, M. Alva, E Seguí et al.|Clinical Cancer Research|2026Cited by 0